Catatan bukti metode

Systemic Lupus Erythematosus Disease Activity Index

The SLEDAI is a comprehensive clinician-assessed measure of systemic lupus erythematosus (SLE) disease activity, capturing manifestations across multiple organ systems (cutaneous, renal, neuropsychiatric, hematologic, and serological). Introduced by Bombardier et al. (1992) and refined as SLEDAI-2K by Gladman et al. (2002), SLEDAI uses weighted scoring of 24 clinical and laboratory features to quantify overall SLE activity. It is the most widely used outcome measure in SLE research and clinical trials, enabling standardised assessment of disease progression, flare prediction, and treatment response in this complex multisystem disease.

Sources recorded, not reviewed

Catatan sumber

Kutipan disalin apa adanya dari catatan sumber metode. Tidak ada verifikasi tingkat klaim yang disimpulkan darinya.

Systemic Lupus Erythematosus Disease Activity Index 2000

Catatan metode taksonomi · process-pipeline / rheumatology

Buka metode lengkap

Klaim yang dikurasi

Klaim tersimpan dalam buku besar bukti, masing-masing dengan penilaiannya sendiri.

Belum ada klaim yang dikurasi

Tampilan ini tidak menciptakan penilaian klaim ketika buku besar tidak memilikinya.

Metode terkait

Dihasilkan dari grafik metode dan ditampilkan sebagai relasi yang disarankan mesin — tidak ada klaim bukti yang disimpulkan.

Taxonomic bucketBath Ankylosing Spondylitis Disease Activity Indexmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDisease Activity Score 28machine-suggested · Relational suggestion, not evidence.Taxonomic bucketRoutine Assessment of Patient Index Data 3machine-suggested · Relational suggestion, not evidence.